Sinopharm Group Co LtdSinopharm Group Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This Disclosure score covers 17 United Nations SDGs including: 'Quality Education', 'Reduced Inequalities' and 'Partnerships for the Goals'. Complete Sustainability assessment of Sinopharm Group Co Ltd are reached by registering for free. Check the bottom of the page for potential risks for Sinopharm Group Co Ltd based on sector, location and marketcap.

Sinopharm Group Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 6.9, social score of 6.0 and governance score of 7.0.

SDG Transparency Score for Sinopharm Group Co Ltd 
Low
0 - 3

6.6

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Sinopharm Group Co Ltd 
6.9

Environmental

6.0

Social

7.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
446STADA Arzneimittel AG
6.7
High
446Valeo Pharma Inc
6.7
High
483Sinopharm Group Co Ltd
6.6
High
483Bal Pharma Ltd
6.6
High
483Adicet Bio Inc
6.6
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Sinopharm Group Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd offer flexible work?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Sinopharm Group Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Sinopharm Group Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Sinopharm Group Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Sinopharm Group Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Sinopharm Group Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Sinopharm Group Co Ltd
These potential risks are based on the size, segment and geographies of the company.

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Sorry!

Failed to process!